Whalesbook
Payment Proposal Rattles Insurers
Major U.S. health insurance stocks experienced a sharp sell-off in Monday's extended trading session. Humana Inc. shares plummeted as much as 13%, while CVS Health Corp. saw a nearly 10% decline. UnitedHealth Group Inc., a significant component of the Dow Jones Industrial Average, shed 9% of its value. This broad-based pressure immediately impacted Dow futures, which fell nearly 150 points in late evening trading. UnitedHealth Group is also slated to report its earnings later the same evening.
Medicare Advantage Funding Squeeze
The catalyst for the market's reaction was a proposal from the Trump administration, released via the Centers for Medicare and Medicaid Services (CMS). The plan outlines an average payment increase of a mere 0.09% for Medicare Advantage (MA) plans for the 2027 calendar year. This figure dramatically undershoots the expectations of Wall Street analysts, who had anticipated a more substantial hike ranging between 4% and 6%.
Understanding Medicare Advantage Rates
Medicare Advantage rate is the fixed monthly sum the U.S. government disbues to private insurance companies contracted to provide healthcare coverage to citizens enrolled in these plans. Upon enrollment in an MA plan, government funds that would typically go to healthcare providers are redirected to these private insurers. If the current proposal is finalized, it would translate to an increase in payments exceeding $700 million for Medicare Advantage plans in 2027. These proposals are generally codified into final rules by April. Currently, more than half of all Medicare beneficiaries opt for MA plans, often attracted by their comparatively lower premiums.